Picture of Arctic Bioscience AS logo

ABS Arctic Bioscience AS News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Arctic Bioscience Aims For Total Year Over Year Revenue Growth In 2023 Of 30-35 %

Aug 29 (Reuters) - Arctic Bioscience AS  ABSA.OL :
    * OUTLOOK: BASED ON RECEIVED ORDER INTAKE FOR SECOND HALF OF
2023
AND GENERAL ORDER OUTLOOK WITH NEW SALES PROSPECTS ARCTIC
BIOSCIENCE AIMS FOR A TOTAL YEAR OVER YEAR REVENUE GROWTH IN
2023 OF 30-35 %
    * OUTLOOK: INCLUDING EFFECTS ALSO FROM ARCTIC ALGAE,
EXPECTED FULL
YEAR EBITDA WILL BE IN RANGE OF NEGATIVE NOK 37-42 MILLION

Source text for Eikon:  ID:nWkr6622Fv 
Further company coverage:  ABSA.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Arctic Bioscience AS

See all news